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Motivation
Many terminologies and ontologies available for 
the domain of phenotypes and diseases, e.g.,
 Disease Ontology
 Mouse Phenotype Pntology
 International Classification of Diseases
 Disease hierarchy of  general terminologies
 SNOMED CT
 Medical Subject Headings (MeSH)
 NCI Thesaurus
 …
Which one to choose for annotation purposes?
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Motivation
 Some issues with existing disease ontologies
 Biological ontologies often do not link to human 
diseases
 Clinical ontologies are not widely used for the 
annotation of biological datasets
 Terminology integration resources are not easy to use
 Incomplete coverage 
 NCI Thesaurus: focus on cancer
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Objectives
 Propose a list of desirable features for an ontology 
of diseases suitable for the annotation of 
biological datasets
Analyze a list of candidate terminologies through 
the framework provided by these features
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Methods  Overview
 Select candidate biomedical ontologies covering 
the subdomain of diseases
Establish a list of desirable characteristics from 
these ontologies
Apply the list of characteristics to each ontology
Rank candidate ontologies by degree of 
compliance with the desirable characteristics
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Candidate ontologies  Methods
Explore repositories of ontologies
BioPortal (NCBO)
 Metadata (“phenotype”, “health”)
Unified Medical Language System (UMLS)
 Expert knowledge
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Candidate ontologies  Results
 Disease ontology (DO)
 Online Mendelian Inheritance in Man (OMIM)
 International Classification of Diseases (ICD)
 SNOMED CT
 Medical Subject Headings (MeSH)
 NCI Thesaurus (NCIt)
 Unified Medical Language System (UMLS)
 Human Phenotype Ontology (HPO)
 Phenotypic Quality Ontology (PATO)
 Mammalian Phenotype Ontology (MPO)
 Logical Observation Identifiers Names and Codes (LOINC)
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Desirable characteristics  Methods
 The ontology must be open and available to be used by all without any 
constraint 
 The ontology is in, or can be expressed in, a common shared syntax. This 
may be either the OBO syntax, extensions of this syntax, or OWL. 
 The ontologies possesses a unique identifier space within the OBO Foundry.
 The ontology provider has procedures for identifying distinct successive 
versions.
 The ontology has a clearly specified and clearly delineated content.
 The ontologies include textual definitions for all terms. 
 The ontology uses relations which are unambiguously defined following the 
pattern of definitions laid down in the OBO Relation Ontology.
 The ontology is well documented.
 The ontology has a plurality of independent users.
 The ontology will be developed collaboratively with other OBO Foundry 
members.
http://www.obofoundry.org/crit.shtml
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Desirable characteristics  Results
No intellectual property restrictions
 Standard, friendly format
Existence of a mapping to clinical terminologies
Harmonization with other biological ontologies
Regular maintenance
Exhaustive coverage of diseases
 Support for automatic reasoning
1
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Example
1 x 1
1 x 1
0 x 2
0 x 2
1 x 1
0.5 x 5
0 x 2
5.5 / 14 = 39%
1
1
0
0
1
2.5
0
5.5
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Desirable characteristics matrix
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Findings
Wide range in the degree of compliance with our 
desirable features
The top 4 contenders
 Are close
 High score for different reasons
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Differences with OBO Foundry principles
 Legacy ontologies
 Not always freely available
 Not always available in OWL or OBO format
 Not always developed collaboratively
 Not always coordinated with other ontologies
 But worth considering
 Coverage
 Mapped to clinical terminologies
 OBO Foundry principles might be too rigid for the 
purpose of selecting disease ontologies for the 
annotation of biological datasetsN
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Limitations
Coarse criteria
Arbitrary weighting scheme
 Needs to be adapted to specific annotation scenarios
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Conclusions
 Framework for evaluating disease ontologies 
available for annotation purposes
Abundance of disease ontologies
 Not necessarily good news to researchers
 Should discourage the development of new ontologies 
in this domain
Annotations made to different ontologies need to 
be reconciled in order to enable semantic 
interoperability
 Role of ontology integration resources
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